drugset / Trial / NCT03154645
Altitude Sickness Prevention With Ibuprofen Relative to Acetazolamide and Treatment Efficacy
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This double blind randomized trial will compare ibuprofen to acetazolamide for the prevention of acute mountain sickness. These drugs have never been directly compared for efficacy. The study population is hikers who are ascending at their own rate under their own power in a true hiking environment at the White Mountain Research Station, Owen Valley Lab (OVL) and Bancroft Station (BAR), Bancroft Peak, White Mountain, California.
Timeline
- Start
- 2017-08-12
- Primary completion
- 2017-10-01
- Completion
- 2017-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Acetazolamide | Small molecule | 125 mg | — |
| Comparator | Ibuprofen | Small molecule | 600 mg | — |